OncLive | Bringing the Global Oncology Community Together

The combination of dabrafenib and trametinib led to encouraging responses in patients with rare, incurable cancer of the digestive tract. Read More >>

Novel Agent Active Across Heavily Pretreated HER2+ Tumors

Capivasertib Effective in AKT-Mutated Cancers

FDA Approves Frontline Eltrombopag for Severe Aplastic Anemia

Nivolumab/Ipilimumab Combo Nears EU Approval for Frontline RCC

Novel Drug Combination Shows Early Activity in Microsatellite Stable CRC

View More Stories >>

View Conference Coverage

2018 Chemotherapy Foundation Symposium

2018 New York Lung Cancers Symposium

2018 State of the Science Summit on Hematologic Malignancies in Clayton

State of the Science Summit on GI Cancers in Newport Beach

2018 ESMO Congress

Dr. Deol on the FDA Approval of Eltrombopag in Severe Aplastic Anemia

Dr. Haigentz on the Potential of Erlotinib and Bevacizumab in EGFR-Mutant NSCLC

Dr. Overman on the Combination of Atezolizumab and Bevacizumab in HCC

Dr. Brufsky on Reducing the Cost of Care in Breast Oncology

Dr. de Wit Discusses Findings With Pembrolizumab in NMIBC

Dr. Chari Discusses the Importance of the ARROW Trial in Myeloma

Dr. Chi on Tazemetostat in Pediatric Patients With INI1-Negative Tumors

OncLive houses thousands of videos that provide updates and information.
See more Videos

The KEYNOTE-024 Precedent for Advanced-NSCLC Treatment

Targeting HER2 Mutations in NSCLC: What Do We Know?

NTRK Gene Fusions: Rare Yet Actionable

Additional Targets in NSCLC: BRAF V600E and BRAF Variants

Second Generation ALK Inhibitors in NSCLC

Practice-Changing Frontline Treatment of ALK+ NSCLC

Updates in the Treatment of ALK+ and ROS1+ NSCLC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Future Management of Metastatic Colorectal Cancer

Emerging Therapy in Metastatic Colorectal Cancer

BEACON Trial: Triplet Therapy in BRAF V600E

$CAR T-Cell Therapies for Relapsed/Refractory NHL$

Surgery for Differentiated Thyroid Cancer

Expert Management of Differentiated Thyroid Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

Expert Anticipates Cure in Acute Lymphoblastic Leukemia

Elias Jabbour, MD, discussed recent clinical trial results in acute lymphoblastic leukemia, the role of immunotherapy, and the biggest challenges facing the field.

View more >>>

Featured

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma.

View more >>>

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approvals in Myeloma, NSCLC, and of a Biosimilar, Priority Review in Gastric Cancer, and More